Publicaciones en colaboración con investigadoras/es de Instituto de Investigación Sanitaria Biocruces Bizkaia (220)

2023

  1. Aluminum alters excitability by inhibiting calcium, sodium, and potassium currents in bovine chromaffin cells

    Journal of Neurochemistry, Vol. 165, Núm. 2, pp. 162-176

  2. Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy

    Frontiers in Aging Neuroscience, Vol. 15

  3. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

    Biomedicines, Vol. 11, Núm. 2

  4. Clinical Management and Assessment of the Early Stages of Psychosis: A Multidimensional Approach

    Methods in molecular biology (Clifton, N.J.), Vol. 2687, pp. 141-150

  5. Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia

    The Cochrane database of systematic reviews, Vol. 7, pp. CD013511

  6. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease (Journal of Neurology, (2023), 270, 1, (519-529), 10.1007/s00415-022-11427-x)

    Journal of Neurology

  7. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies

    Neural Computing and Applications, Vol. 35, Núm. 8, pp. 5603-5617

  8. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  9. Effects of Cannabidiol, Hypothermia, and Their Combination in Newborn Rats with Hypoxic-Ischemic Encephalopathy

    eNeuro, Vol. 10, Núm. 5

  10. Effects of curcumin nanodelivery on schizophrenia and glioblastoma

    International Review of Neurobiology (Academic Press Inc.), pp. 163-203

  11. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment

    International Review of Neurobiology (Academic Press Inc.), pp. 103-143

  12. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

    GLIA, Vol. 71, Núm. 1, pp. 103-126

  13. Enriched environment as a nonpharmacological neuroprotective strategy

    Experimental Biology and Medicine

  14. First-episode psychosis intervention programme versus standard care for the clinical management of early phases of psychosis: Cost analysis

    BJPsych Open, Vol. 10, Núm. 1

  15. Gender differences in the management of acute psychiatric episodes in the emergency department: a cross-sectional analysis of the 2017–2019 triennium

    Archives of Women's Mental Health, Vol. 26, Núm. 6, pp. 777-783